中国生物制药(01177):受托人根据限制性股份奖励计划购买465万股股份
智通财经网·2026-03-27 10:52

Group 1 - The company, China Biopharmaceutical (01177), announced the purchase of 4.65 million shares by a trustee from the market [1] - The average price per share for this transaction was approximately HKD 5.8814 [1] - The shares will be held in trust for selected participants according to the terms and conditions of the plan [1]

SINO BIOPHARM-中国生物制药(01177):受托人根据限制性股份奖励计划购买465万股股份 - Reportify